Stephen Liu leads Melina Marmarelis and Vivek Subbiah in a discussion on the care of patients with RET fusion-positive NSCLC in light of the ARROW trial of pralsetinib.
Meet the faculty
Stephen Liu (Chair)
Dr. Stephen Liu, MD, is an Associate Professor of Medicine, Director of Thoracic Oncology and Director of Developmental Therapeutics at the Lombardi Comprehensive Cancer Center of Georgetown University.
Vivek Subbiah, MD, is an associate professor in the Investigational Cancer Therapeutics department (a Phase 1 program). He is the Center Clinical Medical Director of the Clinical Center for Targeted Therapy, Cancer Medicine division, at The University of Texas MD Anderson Cancer Center.
Melina Marmarelis, MD, MSCE, is an assistant professor at the University of Pennsylvania and the Medical Director of the Penn Medicine Mesothelioma and Pleural Disease Program.